Personalised medicine conference 2016

The Personalised Medicine Conference 2016 is now over. The organising team thanks all speakers and participants for two interesting and thought-provoking days.

Conference presentations

Keynote session

• Ruxandra DRAGHIA-AKLI (European Commission, Directorate for Health Research, DG Research and Innovation) - Conference Welcome
• Paulo LISBOA (Liverpool John Moores University, Applied Mathematics, United Kingdom) - Perspectives on personalised medicine
• Anders OLAUSON (European Patients' Forum - EPF, Belgium) - Personalised medicine: a patient perspective

Session1: Developing Awareness and Empowerment

• Mária Judit MOLNÁR (Ministry of Human Capacities, Hungary) - Opening statement
• Peter KAPITEIN (Inspire2Live, Netherlands) - Patient perspective on Personalised Medicine and how patient organisations empower the community
• Rudi WESTENDORP (University of Copenhagen, Center for Healthy Aging, Department of Public Health, Denmark) - Educational strategies in the era of PM – EITHealth
• Jan GEISSLER (European Patients' Academy (EUPATI), Germany) - The role of patients and healthcare provider in translational medicine
• Panos KANAVOS (London School of Economics - LSE; European Pharmaceutical Forum, United Kingdom) - The health economic impact of increasing patient engagement

Session 2: Integrating Big Data and ICT Solutions

• Wolfgang BALLENSIEFEN (DLR Project Management Agency (DLR PT) - Health Research, Germany)Opening statement
• Ernst HAFEN (ETH Zurich, Institute of Molecular Systems Biology, Switzerland) - Holistic data and citizen data ownership
• Mitzi LÁSZLÓ (Innit Foundation, Netherlands) - Tech and the Human Touch
• Michal ROSEN-ZVI (IBM Research- Haifa, Israel) - The Power of Data
• Janet THORNTON (EMBL - EBI, Research, United Kingdom) - Interpreting Genome Data for Personalised Medicine
• Jaak VILO (University of Tartu, Estonia) - (Big) Health Data for Research
• Andrew MORRIS (University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, United Kingdom) - Options and opportunities in health data science

Session 3: Translating Basic to Clinical Research and Beyond

• Natalia MARTIN (French National Research Agency, Biology and Health, France) - Opening statement
• Nicholas KATSANIS (Duke University, United States of America) - Personalized Medicine. What is it?
• Markus PEROLA (National Institute for Health and Welfare (THL), Health, Finland) - From retrospective patient cohorts into prospective patient cohorts to clinical validation/li>
• David JONES (Newcastle University, United Kingdom) - Stratified Medicine in Primary Biliary Cirrhosis: Understanding Disease Mechanisms and Targeting Therapies
• Sabine TEJPAR (Katholieke Universiteit Leuven, Oncology, Belgium) - Designing clinical trials for personalised medicine

Session 4: Bringing Innovation to the Market

• Peter Høngaard ANDERSEN (Innovation Fund Denmark) - Opening statement - Brining innovative personalised medicine approaches to the market: lessons learned and future challenges

Session 5: Shaping Sustainable Healthcare

• Gaetano GUGLIELMI (Ministry of Health, General Directorate Health Research and Health Innovation, Italy) - Opening statement
• Walter RICCIARDI (ISTITUTO SUPERIORE DI SANITA', Italy) - A framework on impact of PM in National Health Systems
• Frédérique NOWAK (Institut National du Cancer, Research and Innovation Division, France) - Experience of implementing personalised medicine approaches in EU countries - France
• Andres METSPALU (Estonian Genome Center, University of Tartu) - Experience of implementing personalised medicine approaches in EU countries - Estonia

Recorded webstreaming

Day 1 - 01 June 2016

Day 2 - 02 June 2016

Relevant Documents